Literature DB >> 7559452

Stationary phase expression of a novel Escherichia coli outer membrane lipoprotein and its relationship with mammalian apolipoprotein D. Implications for the origin of lipocalins.

R E Bishop1, S S Penfold, L S Frost, J V Höltje, J H Weiner.   

Abstract

We report a novel outer membrane lipoprotein of Escherichia coli. DNA sequencing between ampC and sugE at the 94.5 min region of the E. coli chromosome revealed an open reading frame specifying 177 amino acid residues. Primer extension analysis demonstrated that the promoter is activated at the transition between exponential and stationary growth phases under control of the rpoS sigma factor gene, and this was confirmed in vivo by monitoring expression of beta-galactosidase activity from a lacZ translational fusion. The amino acid sequence exhibited 31% identity with human apolipoprotein D (apoD), which is a component of plasma high density lipoprotein and belongs to the eukaryotic family of lipocalins. The bacterial lipocalin (Blc) contained a short deletion of 7 amino acid residues corresponding to a hydrophobic surface loop that is thought to facilitate the physical interaction between apoD and high density lipoprotein. However, Blc exhibited a typical prokaryotic lipoprotein signal peptide at its amino terminus. Overexpression, membrane fractionation, and metabolic labeling with [3H]palmitate demonstrated that Blc is indeed a globomycin-sensitive outer membrane lipoprotein. Blc represents the first bacterial member of the family of lipocalins and may serve a starvation response function in E. coli.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559452     DOI: 10.1074/jbc.270.39.23097

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein.

Authors:  P D Stapleton; K P Shannon; G L French
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Lethality of the covalent linkage between mislocalized major outer membrane lipoprotein and the peptidoglycan of Escherichia coli.

Authors:  T Yakushi; T Tajima; S Matsuyama; H Tokuda
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

3.  A hydrocarbon ruler measures palmitate in the enzymatic acylation of endotoxin.

Authors:  Victoria E Ahn; Eileen I Lo; Christian K Engel; Lu Chen; Peter M Hwang; Lewis E Kay; Russell E Bishop; Gilbert G Privé
Journal:  EMBO J       Date:  2004-07-22       Impact factor: 11.598

Review 4.  Apolipoprotein D.

Authors:  Eric Rassart; Frederik Desmarais; Ouafa Najyb; Karl-F Bergeron; Catherine Mounier
Journal:  Gene       Date:  2020-06-15       Impact factor: 3.688

5.  Inducible gene expression in Lactobacillus reuteri LTH5531 during type II sourdough fermentation.

Authors:  Fabio Dal Bello; Jens Walter; Stefan Roos; Hans Jonsson; Christian Hertel
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

6.  Identification, expression, and evolutionary analyses of plant lipocalins.

Authors:  Jean-Benoit Frenette Charron; François Ouellet; Mélanie Pelletier; Jean Danyluk; Cédric Chauve; Fathey Sarhan
Journal:  Plant Physiol       Date:  2005-11-23       Impact factor: 8.340

7.  Identification of conserved, RpoS-dependent stationary-phase genes of Escherichia coli.

Authors:  H E Schellhorn; J P Audia; L I Wei; L Chang
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

Review 8.  Linkage map of Escherichia coli K-12, edition 10: the traditional map.

Authors:  M K Berlyn
Journal:  Microbiol Mol Biol Rev       Date:  1998-09       Impact factor: 11.056

Review 9.  The lipocalin protein family: structure and function.

Authors:  D R Flower
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

10.  Diversity and evolution of the small multidrug resistance protein family.

Authors:  Denice C Bay; Raymond J Turner
Journal:  BMC Evol Biol       Date:  2009-06-23       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.